Announcements Trials
Browse Landscape

Phase

Phase NA 61Phase 2 11Phase 3 6Phase 4 4Phase 1 4Phase 1/2 3Phase 2/3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Lymphoid 1

Conditions

Breast Neoplasms 320Leukemia, Myeloid, Acute 266Multiple Myeloma 227Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 202Neoplasms 196Lymphoma 191Colorectal Neoplasms 184Melanoma 179Leukemia 170Recurrence 164Pancreatic Neoplasms 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 160Lung Neoplasms 150Glioblastoma 134Neoplasm Metastasis 132Lymphoma, Non-Hodgkin 128Ovarian Neoplasms 123Leukemia, Lymphocytic, Chronic, B-Cell 120Myelodysplastic Syndromes 117Lymphoma, Large B-Cell, Diffuse 110Lymphoma, Mantle-Cell 108Carcinoma, Hepatocellular 103Lymphoma, Follicular 99Stomach Neoplasms 96Carcinoma, Renal Cell 89Hodgkin Disease 88Brain Neoplasms 88Sarcoma 84Burkitt Lymphoma 75

Interventions

sacubitril and valsartan sodium hydrate drug combination 1Valsartan 1Perindopril 1Bisoprolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Heart Failure × Clear all
NCT05194111 2026-03-13

TREAT-HF

Virginia Commonwealth University

Phase 1/2 Recruiting
53 enrolled

Heart Failure

NCT04737265 2025-07-03

NTproBNP-Guide

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed
101 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiomyopathies, Cardiotoxicity

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown
99 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡